João Silva completed the Masters in Molecular Biology and Genetics in 2018 with a final grade of 16 values and a Degree in Biology in 2016 with a final grade of 14 values, both by the Faculty of Sciences of the University of Lisbon. Currently attends the PhD in Ciências Biomédicas by Cooperativa de Ensino Superior Politécnico e Universitário. Published 4 articles in scientific journals. Submited two articles and one book chapter. Participated in various congresses: EU Cost Action FA1306 with 2 posters, in 2017, Microbiotec with 1 poster, in 2019, I/II Congresso Internacional da TOXRUN with 1 poster, in 2022 and 2023, 4th ENJIO with 1 poster, in 2022, and UNIPRO with a oral presentation. Participated as Master Student Fellow in the project "An RNA-based approach to bacterial infection: The function of PNPase and regulatory noncoding RNAs in Listeria virulence" and as a PhD student in the projects "The second-generation antimitotics: a second chance?", "Studies of molecular mechanisms of flavonoid derivatives with potential antitumor activity" and "Overcoming paclitaxel resistance in ovarian cancer".
João Silva completed the Masters in Molecular Biology and Genetics in 2018 with a final grade of 16 values and a Degree in Biology in 2016 with a final grade of 14 values, both by the Faculty of Sciences of the University of Lisbon. Currently attends the PhD in Ciências Biomédicas by Cooperativa de Ensino Superior Politécnico e Universitário. Published 4 articles in scientific journals. Submited two articles and one book chapter. Participated in various congresses: EU Cost Action FA1306 with 2 posters, in 2017, Microbiotec with 1 poster, in 2019, I/II Congresso Internacional da TOXRUN with 1 poster, in 2022 and 2023, 4th ENJIO with 1 poster, in 2022, and UNIPRO with a oral presentation. Participated as Master Student Fellow in the project "An RNA-based approach to bacterial infection: The function of PNPase and regulatory noncoding RNAs in Listeria virulence" and as a PhD student in the projects "The second-generation antimitotics: a second chance?", "Studies of molecular mechanisms of flavonoid derivatives with potential antitumor activity" and "Overcoming paclitaxel resistance in ovarian cancer".
PhD student